Volume 9, Issue 11 pp. 1286-1297
Research Article

An additive manufacturing-based PCL–alginate–chondrocyte bioprinted scaffold for cartilage tissue engineering

Joydip Kundu

Joydip Kundu

Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Kyungbuk, South Korea

These authors contributed equally to this study.

Search for more papers by this author
Jin-Hyung Shim

Jin-Hyung Shim

Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Kyungbuk, South Korea

These authors contributed equally to this study.

Search for more papers by this author
Jinah Jang

Jinah Jang

Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Kyungbuk, South Korea

Search for more papers by this author
Sung-Won Kim

Sung-Won Kim

Department of Otolaryngology-Head and Neck Surgery, The Catholic University of Korea, College of Medicine, Seoul, Korea

Search for more papers by this author
Dong-Woo Cho

Corresponding Author

Dong-Woo Cho

Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Kyungbuk, South Korea

Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Kyungbuk, South Korea

Correspondence to: Dong-Woo Cho, Division of Biosciences and Biotechnology and Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), San 31, Hyoja-dong, Nam-gu, Pohang, Kyungbuk, 790-784, South Korea. E-mail: [email protected]Search for more papers by this author
First published: 24 January 2013
Citations: 468

Abstract

Regenerative medicine is targeted to improve, restore or replace damaged tissues or organs using a combination of cells, materials and growth factors. Both tissue engineering and developmental biology currently deal with the process of tissue self-assembly and extracellular matrix (ECM) deposition. In this investigation, additive manufacturing (AM) with a multihead deposition system (MHDS) was used to fabricate three-dimensional (3D) cell-printed scaffolds using layer-by-layer (LBL) deposition of polycaprolactone (PCL) and chondrocyte cell-encapsulated alginate hydrogel. Appropriate cell dispensing conditions and optimum alginate concentrations for maintaining cell viability were determined. In vitro cell-based biochemical assays were performed to determine glycosaminoglycans (GAGs), DNA and total collagen contents from different PCL–alginate gel constructs. PCL–alginate gels containing transforming growth factor-β (TGFβ) showed higher ECM formation. The 3D cell-printed scaffolds of PCL–alginate gel were implanted in the dorsal subcutaneous spaces of female nude mice. Histochemical [Alcian blue and haematoxylin and eosin (H&E) staining] and immunohistochemical (type II collagen) analyses of the retrieved implants after 4 weeks revealed enhanced cartilage tissue and type II collagen fibril formation in the PCL–alginate gel (+TGFβ) hybrid scaffold. In conclusion, we present an innovative cell-printed scaffold for cartilage regeneration fabricated by an advanced bioprinting technology. Copyright © 2013 John Wiley & Sons, Ltd.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.